Literature DB >> 11704096

High rate of bacterial vaginosis among women with intrauterine devices in Manado, Indonesia.

M R Joesoef1, A Karundeng, C Runtupalit, J S Moran, J S Lewis, C A Ryan.   

Abstract

Recent research reported that bacterial vaginosis (BV) might enhance the acquisition and transmission of HIV. BV is also associated with an increased risk of pelvic inflammatory disease, a disease also associated with intrauterine device (IUD) insertion. To measure the magnitude of this problem, we conducted a prevalence survey of BV and sexually transmitted diseases (STDs; defined as current infections with Neisseria gonorrhoeae, Chlamydia trachomatis, and/or Trichomonas vaginalis) among all patients attending a family planning clinic in Manado from May to July 1999. BV was diagnosed by Gram stain using Nugent's criteria and vaginal trichomoniasis by wet mount or culture. Cervical infections with C. trachomatis and N. gonorrhoeae were diagnosed by DNA probe. Of 357 patients, 116 (32.5%) had BV, 83 (23.3%) had trichomoniasis, 9 (2.5%) had chlamydia, and 8 (2.2%) had gonorrhea. The prevalence of STD was similar among users of all types of contraception. However, BV was more common among IUD users (47.2%) than among non-IUD users (29.9%). This association persisted after controlling for age, education, ever had douching, and any STD (odds ratio 2.0, 95% CI 1.1-3.8). BV was also associated with STD (41.3% in women with STD vs. 29.4% in women without). This association remained significant after adjusting for age, education, ever had douching, and IUD use (odds ratio 1.7, 95% CI 1.1-2.9). Because we found that BV was associated with IUDs and that other studies reported that both BV and IUDs were associated with pelvic inflammatory disease, a Gram stain evaluation of BV may be considered prior to IUD insertion

Entities:  

Mesh:

Year:  2001        PMID: 11704096     DOI: 10.1016/s0010-7824(01)00246-3

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  12 in total

1.  Midtrimester bacterial vaginosis and cervical length in women at risk for preterm birth.

Authors:  Melissa S Mancuso; Dana Figueroa; Jeff M Szychowski; Merri Maddox Paden; John Owen
Journal:  Am J Obstet Gynecol       Date:  2010-12-22       Impact factor: 8.661

2.  Risk of bacterial vaginosis in users of the intrauterine device: a longitudinal study.

Authors:  Tessa Madden; Jaclyn M Grentzer; Gina M Secura; Jenifer E Allsworth; Jeffrey F Peipert
Journal:  Sex Transm Dis       Date:  2012-03       Impact factor: 2.830

3.  Use of species-directed 16S rRNA gene PCR primers for detection of Atopobium vaginae in patients with bacterial vaginosis.

Authors:  Michael J Ferris; Alicia Masztal; David H Martin
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

Review 4.  The rationale for probiotics in female urogenital healthcare.

Authors:  Gregor Reid; Jeremy Burton; Estelle Devillard
Journal:  MedGenMed       Date:  2004-03-29

5.  Organisms associated with bacterial vaginosis in Nigerian women as determined by PCR-DGGE and 16S rRNA gene sequence.

Authors:  Kingsley C Anukam; Gregor Reid
Journal:  Afr Health Sci       Date:  2007-06       Impact factor: 0.927

Review 6.  Bacterial vaginosis-A brief synopsis of the literature.

Authors:  Makella S Coudray; Purnima Madhivanan
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2019-12-24       Impact factor: 2.435

7.  Prevalence of trichomoniasis among women in kermanshah, iran.

Authors:  Naser Nazari; Maryam Zangeneh; Fatemeh Moradi; Arezoo Bozorgomid
Journal:  Iran Red Crescent Med J       Date:  2015-03-31       Impact factor: 0.611

Review 8.  Hormonal contraception is associated with a reduced risk of bacterial vaginosis: a systematic review and meta-analysis.

Authors:  Lenka A Vodstrcil; Jane S Hocking; Matthew Law; Sandra Walker; Sepehr N Tabrizi; Christopher K Fairley; Catriona S Bradshaw
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

9.  Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis.

Authors:  Michael J Ferris; Alicia Masztal; Kenneth E Aldridge; J Dennis Fortenberry; Paul L Fidel; David H Martin
Journal:  BMC Infect Dis       Date:  2004-02-13       Impact factor: 3.090

10.  Bacterial vaginosis: Prevalence and associated risk factors among non-pregnant women of reproductive age attending a Nigerian tertiary hospital.

Authors:  Rasheedat M Abdullateef; Munirdeen A Ijaiya; Fadeyi Abayomi; Abiodun S Adeniran; Haruna Idris
Journal:  Malawi Med J       Date:  2017-12       Impact factor: 0.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.